Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Aprea Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −7 vs. Q2 2022
- Shares held
- 1.71M
- −327.2K (−16.1%) vs. Q2 2022
- Total value
- $1.11M
- −$410.7K (−27.0%) vs. Q2 2022
- New holders
- 1
- 1 more added
- Sold out
- 8
- 13 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 312,016 | $202.0K | 0.00% | −39,820−11.3% | Reduced |
| Vanguard Group Inc | 309,598 | $201.0K | 0.00% | −45,892−12.9% | Reduced |
| Renaissance Technologies LLC | 282,541 | $184.0K | 0.00% | −29,213−9.4% | Reduced |
| BlackRock Inc. | 185,741 | $121.0K | 0.00% | −1,038−0.6% | Reduced |
| Geode Capital Management, LLC | 150,142 | $97.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 121,333 | $79.0K | 0.00% | +111,078+1,083.2% | Added |
| BNP Paribas Arbitrage, SA | 61,847 | $40.2K | 0.00% | +61,847 | New |
| State Street Corp | 40,832 | $27.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 31,003 | $20.0K | 0.00% | −1,800−5.5% | Reduced |
| Northern Trust Corp | 28,710 | $19.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 22,318 | $15.0K | 0.00% | −25,044−52.9% | Reduced |
| Bridgeway Capital Management, LLC | 20,000 | $13.0K | 0.00% | −25,000−55.6% | Reduced |
| The PNC Financial Services Group, Inc. | 20,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 20,101 | $13.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,662 | $11.0K | 0.00% | −44,295−71.5% | Reduced |
| Two Sigma Investments, LP | 16,843 | $11.0K | 0.00% | −43,540−72.1% | Reduced |
| Blackstone Group Inc. | 16,590 | $11.0K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 12,519 | $8.14K | 0.00% | −2,181−14.8% | Reduced |
| Advisor Group Holdings, Inc. | 11,628 | $8.00K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 10,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,942 | $4.00K | 0.00% | −4,390−42.5% | Reduced |
| Sugarloaf Wealth Management, LLC | 5,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,465 | $2.00K | 0.00% | −226−6.1% | Reduced |
| JPMorgan Chase & Co | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 140 | $0 | 0.00% | −467−76.9% | Reduced |
| Kistler-Tiffany Companies, LLC | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Quent Capital, LLC | 75 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −71,959−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −49,750−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −48,819−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,664−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,881−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −16,643−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −11,352−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −198−100.0% | Sold out |